Should I buy or sell Ryan Specialty stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ryan Specialty in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" RYAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RYAN, but not buy additional shares or sell existing shares. View RYAN analyst ratings or view top-rated stocks .

What is Ryan Specialty's stock price target for 2024?

7 equities research analysts have issued twelve-month target prices for Ryan Specialty's shares. Their RYAN share price targets range from $43.00 to $59.00. On average, they predict the company's stock price to reach $51.14 in the next twelve months. This suggests a possible upside of 12.4% from the stock's current price. View analysts price targets for RYAN or view top-rated stocks among Wall Street analysts .

How have RYAN shares performed in 2023?

Ryan Specialty's stock was trading at $41.51 at the start of the year. Since then, RYAN stock has increased by 9.6% and is now trading at $45.49. View the best growth stocks for 2023 here .

When is Ryan Specialty's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our RYAN earnings forecast .

How were Ryan Specialty's earnings last quarter?

Ryan Specialty Holdings, Inc. (NYSE:RYAN) announced its quarterly earnings results on Thursday, November, 2nd. The company reported $0.32 earnings per share for the quarter, hitting the consensus estimate of $0.32. The business had revenue of $501.94 million for the quarter, compared to the consensus estimate of $500.92 million. Ryan Specialty had a net margin of 9.18% and a trailing twelve-month return on equity of 42.39%.

What ETFs hold Ryan Specialty's stock?

ETFs with the largest weight of Ryan Specialty (NYSE:RYAN) stock in their portfolio include SPDR S&P Insurance ETF (KIE) , Invesco Dorsey Wright Financial Momentum ETF (PFI) , Renaissance IPO ETF (IPO) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC) . Nuveen ESG Small-Cap ETF (NUSC) .

When did Ryan Specialty IPO?

(RYAN) raised $1.3 billion in an IPO on Thursday, July 22nd 2021. The company issued 56,918,278 shares at $22.00-$25.00 per share.

Who are Ryan Specialty's major shareholders?

Ryan Specialty's stock is owned by a variety of institutional and retail investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (3.92%), Artisan Partners Limited Partnership (1.09%), Blair William & Co. IL (1.02%), Morgan Stanley (0.81%), Victory Capital Management Inc. (0.69%) and Ameriprise Financial Inc. (0.57%). Insiders that own company stock include Brendan Martin Mulshine, Corp Onex, David P Bolger , Lisa Jo Paschal-Alcorn , Mark Stephen Katz , Michael D Ohalleran , Michael Thomas Vanacker , Nicholas Dominic Cortezi , Patrick G Ryan and Timothy William Turner . View institutional ownership trends .

How do I buy shares of Ryan Specialty?

Shares of RYAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Ryan Specialty Stock Price, News & Analysis (NYSE:RYAN)

$45.43

+0.03 (+0.07%)

(As of 12:33 PM ET)

Compare

Today's Range: $45.23
▼
$45.57
50-Day Range: $43.15
▼
$49.33
52-Week Range: $35.10
▼
$50.64

Volume: 127,519 shs
Average Volume: 661,635 shs
Market Capitalization: $11.82 billion

P/E Ratio: 96.66
Dividend Yield: N/A
Price Target: $51.14

Ryan Specialty MarketRank™ Stock Analysis

Analyst Rating: Hold
2.43 Rating Score
Upside/Downside: 12.4% Upside
$51.14 Price Target
Short Interest: Bearish
6.05% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$471,656 Sold Last Quarter
Proj. Earnings Growth: 23.19%
From $1.38 to $1.70 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Finance Sector

465th out of 860 stocks

Insurance Agents, Brokers, & Service Industry

11th out of 16 stocks

3.2

Analyst's Opinion

Consensus Rating
Ryan Specialty has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 3 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $51.14, Ryan Specialty has a forecasted upside of 12.4% from its current price of $45.49.
Amount of Analyst Coverage
Ryan Specialty has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.0

Short Interest

Percentage of Shares Shorted
6.05% of the float of Ryan Specialty has been sold short.
Short Interest Ratio / Days to Cover
Ryan Specialty has a short interest ratio ("days to cover") of 9.1.
Change versus previous month
Short interest in Ryan Specialty has recently decreased by 4.98%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Ryan Specialty does not currently pay a dividend.
Dividend Growth
Ryan Specialty does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for RYAN.

0.9

News and Social Media Coverage

News Sentiment
Ryan Specialty has a news sentiment score of -0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Finance companies.
MarketBeat Follows
Only 2 people have added Ryan Specialty to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ryan Specialty insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $471,656.00 in company stock.
Percentage Held by Insiders
54.51% of the stock of Ryan Specialty is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 34.09% of the stock of Ryan Specialty is held by institutions.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Ryan Specialty are expected to grow by 23.19% in the coming year, from $1.38 to $1.70 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Ryan Specialty is 96.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.81.
Price to Earnings Ratio vs. Sector
The P/E ratio of Ryan Specialty is 96.79, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 46.25.
Price to Book Value per Share Ratio
Ryan Specialty has a P/B Ratio of 12.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Ryan Specialty Stock (NYSE:RYAN)

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.

RYAN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RYAN Stock News Headlines

November 22, 2023 | americanbankingnews.com

The Goldman Sachs Group Downgrades Ryan Specialty (NYSE:RYAN) to Neutral

November 20, 2023 | msn.com

Goldman Sachs Downgrades Ryan Specialty Holdings Inc (RYAN)

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 20, 2023 | markets.businessinsider.com

What 4 Analyst Ratings Have To Say About Ryan Specialty Hldgs

November 14, 2023 | msn.com

Ryan Bridge asks Nicky Styris' husband 'what's she like at home' amid 'iron fist' discussion

November 6, 2023 | finance.yahoo.com

Ryan Specialty Holdings, Inc.'s (NYSE:RYAN) P/S Is On The Mark

November 5, 2023 | msn.com

Daisy Ridley Stars In ‘The Marsh King's Daughter', Meg Ryan's Rom-Com Return, ‘Priscilla' Expands – Specialty Preview

November 4, 2023 | finance.yahoo.com

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Q3 2023 Earnings Call Transcript

November 29, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

November 3, 2023 | finance.yahoo.com

Ryan Specialty Group (RYAN) Meets Q3 Earnings Estimates

November 2, 2023 | finance.yahoo.com

Ryan Specialty Reports Third Quarter 2023 Results

November 2, 2023 | finance.yahoo.com

Ryan Specialty Holdings Inc (RYAN) Reports 21.8% YoY Revenue Growth in Q3 2023

November 1, 2023 | health.usnews.com

Ryan T. Johnson

November 1, 2023 | axios.com

Exclusive: Free Market Health raises $20M Series B

November 1, 2023 | msn.com

BMO Capital Downgrades Ryan Specialty Holdings Inc (RYAN)

October 31, 2023 | finance.yahoo.com

Ryan Specialty Appoints to Its Board of Directors Anthony J. Kuczinski, Former President & CEO of Munich Re US

October 31, 2023 | msn.com

Speciality insurance company Ryan Specialty to acquire AccuRisk

October 30, 2023 | marketwatch.com

Ryan Specialty to Acquire AccuRisk Holdings

October 30, 2023 | bizjournals.com

Doctors buy Glens Falls building to renovate as new speciality veterinary practice

October 30, 2023 | msn.com

Ryan Specialty Holdings downgraded at BMO on negative seasonality

October 30, 2023 | finance.yahoo.com

Ryan Specialty Signs Definitive Agreement To Acquire AccuRisk Holdings

October 30, 2023 | finance.yahoo.com

AccuRisk Holdings to be Acquired by Ryan Specialty

October 30, 2023 | msn.com

Chester County is getting a new DA. Both candidates are touting law enforcement changes — especially after Cavalcante’s escape

October 26, 2023 | finance.yahoo.com

Arthur J. Gallagher (AJG) Tops Q3 Earnings and Revenue Estimates

October 24, 2023 | nz.news.yahoo.com

Gotham Awards Nominations: ‘All Of Us Strangers’ Tops Movie List; Ryan Gosling Gets ‘Barbie’ Nom With Budget Caps Removed

October 24, 2023 | finance.yahoo.com

Risk Strategies Acquires North Bay Business Unit of InterWest Insurance Services, Expands Wineries Specialty Capabilities

October 19, 2023 | omaha.com

OrthoNebraska expands services, walk-in care in Omaha metro

See More Headlines

Receive RYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ryan Specialty and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/02/2023
Today: 11/29/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/27/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Insurance agents, brokers, & service
Sub-Industry: N/A
Sector: Finance
Current Symbol: NYSE:RYAN
CUSIP: N/A
CIK: 1849253
Web: ryansg.com
Phone: 312-784-6001
Fax: N/A
Employees: 3,850
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $51.14
High Stock Price Target: $59.00
Low Stock Price Target: $43.00
Potential Upside/Downside: +12.5%
Consensus Rating: Hold
Rating Score (0-4): 2.43
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.47
Trailing P/E Ratio: 96.73
Forward P/E Ratio: 32.94
P/E Growth: N/A
Net Income: $61.05 million
Net Margins: 9.18%
Pretax Margin: 11.64%
Return on Equity: 42.39%
Return on Assets: 5.78%

Debt

Debt-to-Equity Ratio: 2.07
Current Ratio: 1.20
Quick Ratio: 1.20

Sales & Book Value

Annual Sales: $1.73 billion
Price / Sales: 6.86
Cash Flow: $1.66 per share
Price / Cash Flow: 27.38
Book Value: $3.62 per share
Price / Book: 12.56

Miscellaneous

Outstanding Shares: 260,250,000
Free Float: 118,388,000
Market Cap: $11.83 billion
Optionable: Not Optionable
Beta: 0.46

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Patrick G. Ryan (Age 85)
Chairman & CEO
Comp: $4.48M
Mr. Timothy William Turner (Age 62)
President & Director
Comp: $3.97M
Mr. Jeremiah Rawlins Bickham (Age 37)
Executive VP & CFO
Comp: $1.62M
Mr. Mark Stephen Katz Esq. (Age 54)
Executive VP, General Counsel & Corporate Secretary
Comp: $1.56M
Mr. Brendan Martin Mulshine (Age 57)
Executive VP & Chief Revenue Officer
Comp: $1.74M
Mr. Kirk A. Behrens
Executive Vice President of Operations, Technology & Data Analytics
Ms. Janice M. Hamilton
Senior VP, Controller & Chief Accounting Officer
Mr. Bradley Eames Bodell B.S. (Age 57)
Chief Information Officer
Mr. Mark C. Melander
Chief Administrative Officer
Mr. Nicholas J. Mezick C.F.A.
Director of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RYAN Stock Analysis - Frequently Asked Questions

Should I buy or sell Ryan Specialty stock right now?: 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ryan Specialty in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" RYAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RYAN, but not buy additional shares or sell existing shares.
View RYAN analyst ratings or view top-rated stocks.
What is Ryan Specialty's stock price target for 2024?: 7 equities research analysts have issued twelve-month target prices for Ryan Specialty's shares. Their RYAN share price targets range from $43.00 to $59.00. On average, they predict the company's stock price to reach $51.14 in the next twelve months. This suggests a possible upside of 12.4% from the stock's current price.
View analysts price targets for RYAN or view top-rated stocks among Wall Street analysts.
How have RYAN shares performed in 2023?: Ryan Specialty's stock was trading at $41.51 at the start of the year. Since then, RYAN stock has increased by 9.6% and is now trading at $45.49.
View the best growth stocks for 2023 here.
When is Ryan Specialty's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our RYAN earnings forecast.
How were Ryan Specialty's earnings last quarter?: Ryan Specialty Holdings, Inc. (NYSE:RYAN) announced its quarterly earnings results on Thursday, November, 2nd. The company reported $0.32 earnings per share for the quarter, hitting the consensus estimate of $0.32. The business had revenue of $501.94 million for the quarter, compared to the consensus estimate of $500.92 million. Ryan Specialty had a net margin of 9.18% and a trailing twelve-month return on equity of 42.39%.

What ETFs hold Ryan Specialty's stock?: ETFs with the largest weight of Ryan Specialty (NYSE:RYAN) stock in their portfolio include SPDR S&P Insurance ETF (KIE), Invesco Dorsey Wright Financial Momentum ETF (PFI), Renaissance IPO ETF (IPO) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC).Nuveen ESG Small-Cap ETF (NUSC).
When did Ryan Specialty IPO?: (RYAN) raised $1.3 billion in an IPO on Thursday, July 22nd 2021. The company issued 56,918,278 shares at $22.00-$25.00 per share.
Who are Ryan Specialty's major shareholders?: Ryan Specialty's stock is owned by a variety of institutional and retail investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (3.92%), Artisan Partners Limited Partnership (1.09%), Blair William & Co. IL (1.02%), Morgan Stanley (0.81%), Victory Capital Management Inc. (0.69%) and Ameriprise Financial Inc. (0.57%). Insiders that own company stock include Brendan Martin Mulshine, Corp Onex, David P Bolger, Lisa Jo Paschal-Alcorn, Mark Stephen Katz, Michael D Ohalleran, Michael Thomas Vanacker, Nicholas Dominic Cortezi, Patrick G Ryan and Timothy William Turner.
View institutional ownership trends.
How do I buy shares of Ryan Specialty?: Shares of RYAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:RYAN) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial